By Huang Jianwen King & Wood Mallesons’ Commercial & Regulatory Group

Wehuang_jianwen have analyzed drug policies with regard to drug pricing and the centralized procurement of drugs in the previous Key 2015 Healthcare and Pharmaceutical Policies: Pharmaceuticals. This article will sort out China’s key regulations and policies in 2015 related to healthcare from five aspects – public hospital reforms, private investments in the healthcare sector, the removal of the administrative review and approval of healthcare insurance designated institutions, the combination of healthcare and elderly care services, and the investment of foreign capital in healthcare institutions.

Read full article, please click here.